{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:08:02Z","timestamp":1784192882737,"version":"3.55.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23gm0010006h"],"award-info":[{"award-number":["23gm0010006h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03446"],"award-info":[{"award-number":["20H03446"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H05122"],"award-info":[{"award-number":["21H05122"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) encompasses multiple pathogenic mechanisms manifested by inflammation, fibrosis, oxidative stress and cell death. We previously showed that circulating protein CD5L (or AIM) ameliorates acute kidney injury, so we explored its effect in a mouse model of unilateral ureteral obstruction (UUO)-induced renal fibrosis. Here, we show a unique kidney-protective pathway mediated by CD5L. CD5L is endocytosed into renal epithelial cells, where it reduces oxidative stress, decreasing cell injury and death. This effect is supported by both a cysteine-dependent direct antioxidant activity of CD5L and enhancement of Nrf2-associated antioxidant responses. In addition, our data suggest that suppression of sphingomyelinase activity and reduction of cellular ceramide may contribute, at least in part, to CD5L-associated augmentation of Nrf2 nuclear transport. These effects depend on the reactive cysteine residue on the CD5L surface. Consistent with these findings, recombinant CD5L treatment in UUO mice reduces sphingomyelinase activity, activates Nrf2, and lowers oxidative stress, alleviating inflammation, fibrosis, and kidney injury. Our findings uncover a novel antioxidant pathway mediated by CD5L with potential implications for CKD-associated fibrotic mechanisms.<\/jats:p>","DOI":"10.1038\/s41420-026-03171-2","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:36:50Z","timestamp":1779511010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A kidney-protective mechanism via cellular oxidative stress reduction induced by CD5L protein"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5410-3334","authenticated-orcid":false,"given":"Kai","family":"Kudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aika","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-4362","authenticated-orcid":false,"given":"Toru","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"3171_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","volume":"16","author":"M Ruiz-Ortega","year":"2020","unstructured":"Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16:269\u201388.","journal-title":"Nat Rev Nephrol"},{"key":"3171_CR2","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010006","volume":"26","author":"MA Venkatachalam","year":"2015","unstructured":"Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26:1765\u201376.","journal-title":"J Am Soc Nephrol"},{"key":"3171_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1681\/ASN.2005070757","volume":"17","author":"M Nangaku","year":"2006","unstructured":"Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17:17\u201325.","journal-title":"J Am Soc Nephrol"},{"key":"3171_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1681\/ASN.2016050562","volume":"28","author":"B Thomas","year":"2017","unstructured":"Thomas B, Matsushita K, Abate KH, Al-Aly Z, \u00c4rnl\u00f6v J, Asayama K, et al. Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol. 2017;28:2167\u201379.","journal-title":"J Am Soc Nephrol"},{"key":"3171_CR5","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1053\/j.ajkd.2009.09.035","volume":"55","author":"LA Stevens","year":"2010","unstructured":"Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010;55:S23\u201333.","journal-title":"Am J Kidney Dis"},{"key":"3171_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.kint.2016.07.038","volume":"91","author":"J B\u00e1b\u00ed\u010dkov\u00e1","year":"2017","unstructured":"B\u00e1b\u00ed\u010dkov\u00e1 J, Klinkhammer BM, Buhl EM, Djudjaj S, Hoss M, Heymann F, et al. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney Int. 2017;91:70\u201385.","journal-title":"Kidney Int"},{"key":"3171_CR7","doi-asserted-by":"publisher","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","volume":"304","author":"M Zeisberg","year":"2013","unstructured":"Zeisberg M, Kalluri R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol. 2013;304:C216\u201325.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3171_CR8","first-page":"281","volume":"8","author":"DA Papazova","year":"2015","unstructured":"Papazova DA, Oosterhuis NR, Gremmels H, van Koppen A, Joles JA, Verhaar MC. Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis. Dis Model Mech. 2015;8:281\u201393.","journal-title":"Dis Model Mech"},{"key":"3171_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00467-011-1992-9","volume":"27","author":"KS Hodgkins","year":"2012","unstructured":"Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol. 2012;27:901\u20139.","journal-title":"Pediatr Nephrol"},{"key":"3171_CR10","doi-asserted-by":"publisher","first-page":"i89","DOI":"10.1093\/ndt\/gfw388","volume":"32","author":"IA Leaf","year":"2017","unstructured":"Leaf IA, Duffield JS. What can target kidney fibrosis? Nephrol Dial Transpl. 2017;32:i89\u2013i97.","journal-title":"Nephrol Dial Transpl"},{"key":"3171_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","volume":"10","author":"XM Meng","year":"2014","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10:493\u2013503.","journal-title":"Nat Rev Nephrol"},{"key":"3171_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fmed.2015.00052","volume":"2","author":"N Simon","year":"2015","unstructured":"Simon N, Hertig A. Alteration of fatty acid oxidation in tubular epithelial cells: from acute kidney injury to renal fibrogenesis. Front Med. 2015;2:52.","journal-title":"Front Med"},{"key":"3171_CR13","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/jcm4061325","volume":"4","author":"MV Perez-Gomez","year":"2015","unstructured":"Perez-Gomez MV, Sanchez-Ni\u00f1o MD, Sanz AB, Mart\u00edn-Cleary C, Ruiz-Ortega M, Egido J, et al. Horizon 2020 in Diabetic kidney disease: the clinical trial pipeline for add-on therapies on top of renin angiotensin system blockade. J Clin Med. 2015;4:1325\u201347.","journal-title":"J Clin Med"},{"key":"3171_CR14","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1172\/JCI72267","volume":"124","author":"JS Duffield","year":"2014","unstructured":"Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124:2299\u2013306.","journal-title":"J Clin Invest"},{"key":"3171_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/0886022X.2014.964141","volume":"37","author":"G Xu","year":"2015","unstructured":"Xu G, Luo K, Liu H, Huang T, Fang X, Tu W. The progress of inflammation and oxidative stress in patients with chronic kidney disease. Ren Fail. 2015;37:45\u20139.","journal-title":"Ren Fail"},{"key":"3171_CR16","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1080\/10715760903165003","volume":"43","author":"A Pieniazek","year":"2009","unstructured":"Pieniazek A, Brzeszczynska J, Kruszynska I, Gwozdzinski K. Investigation of albumin properties in patients with chronic renal failure. Free Radic Res. 2009;43:1008\u201318.","journal-title":"Free Radic Res"},{"key":"3171_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000350726","volume":"122","author":"DM Small","year":"2012","unstructured":"Small DM, Bennett NC, Roy S, Gabrielli BG, Johnson DW, Gobe GC. Oxidative stress and cell senescence combine to cause maximal renal tubular epithelial cell dysfunction and loss in an in vitro model of kidney disease. Nephron Exp Nephrol. 2012;122:123\u201330.","journal-title":"Nephron Exp Nephrol"},{"key":"3171_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","volume":"83","author":"H Watanabe","year":"2013","unstructured":"Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 2013;83:582\u201392.","journal-title":"Kidney Int"},{"key":"3171_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1744-9987.2010.00887.x","volume":"15","author":"M Morita","year":"2011","unstructured":"Morita M, Yano S, Yamaguchi T, Yamauchi M, Sugimoto T. Phenylacetic acid stimulates reactive oxygen species generation and tumor necrosis factor-\u03b1 secretion in vascular endothelial cells. Ther Apher Dial. 2011;15:147\u201350.","journal-title":"Ther Apher Dial"},{"key":"3171_CR20","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25:1897\u2013907.","journal-title":"J Am Soc Nephrol"},{"key":"3171_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2215\/CJN.04291007","volume":"3","author":"E Linden","year":"2008","unstructured":"Linden E, Cai W, He JC, Xue C, Li Z, Winston J, et al. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol. 2008;3:691\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3171_CR22","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028\u201340.","journal-title":"Nat Med"},{"key":"3171_CR23","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJ, Charytan DM, et al. Canagliflozin and renal outcomes in Type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295\u2013306.","journal-title":"N Engl J Med"},{"key":"3171_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861\u20139.","journal-title":"N Engl J Med"},{"key":"3171_CR25","first-page":"5519","volume":"163","author":"HH Parving","year":"2001","unstructured":"Parving HH, Lehnert H, Br\u00f8chner-Mortensen J, Gomis R, Andersen S, Arner P. [Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes]. Ugeskr Laege. 2001;163:5519\u201324.","journal-title":"Ugeskr Laege"},{"key":"3171_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851\u201360.","journal-title":"N Engl J Med"},{"key":"3171_CR27","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med. 2017;377:1930\u201342.","journal-title":"N Engl J Med"},{"key":"3171_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1681\/ASN.2014010012","volume":"26","author":"JF Navarro-Gonz\u00e1lez","year":"2015","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C, Muros de Fuentes M, Chahin J, M\u00e9ndez ML, Gallego E, et al. Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial. J Am Soc Nephrol. 2015;26:220\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"3171_CR29","first-page":"Cd008176","volume":"10","author":"M Jun","year":"2012","unstructured":"Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, et al. Antioxidants for chronic kidney disease. Cochrane Database Syst Rev. 2012;10:Cd008176.","journal-title":"Cochrane Database Syst Rev"},{"key":"3171_CR30","doi-asserted-by":"publisher","first-page":"1342.","DOI":"10.3390\/cells9061342","volume":"9","author":"MV Irazabal","year":"2020","unstructured":"Irazabal MV, Torres VE. Reactive oxygen species and redox signaling in chronic kidney disease. Cells. 2020;9:1342.","journal-title":"Cells"},{"key":"3171_CR31","doi-asserted-by":"publisher","first-page":"1669.","DOI":"10.3390\/antiox10111669","volume":"10","author":"AG Casanova","year":"2021","unstructured":"Casanova AG, L\u00f3pez-Hern\u00e1ndez FJ, Vicente-Vicente L, Morales AI. Are antioxidants useful in preventing the progression of chronic kidney disease?. Antioxidants. 2021;10:1669.","journal-title":"Antioxidants"},{"key":"3171_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92753-4","volume":"11","author":"JH Fang","year":"2021","unstructured":"Fang JH, Chen YC, Ho CH, Chen JY, Hsing CH, Liang FW, et al. The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment. Sci Rep. 2021;11:13521.","journal-title":"Sci Rep"},{"key":"3171_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","volume":"20","author":"S Kishi","year":"2024","unstructured":"Kishi S, Nagasu H, Kidokoro K, Kashihara N. Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol. 2024;20:101\u201319.","journal-title":"Nat Rev Nephrol"},{"key":"3171_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.270.5234.296","volume":"270","author":"M Sundaresan","year":"1995","unstructured":"Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270:296\u20139.","journal-title":"Science"},{"key":"3171_CR35","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1126\/science.1130481","volume":"312","author":"SG Rhee","year":"2006","unstructured":"Rhee SG. Cell signaling. H2O2, a necessary evil for cell signaling. Science. 2006;312:1882\u20133.","journal-title":"Science"},{"key":"3171_CR36","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","volume":"122","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive Oxygen Species in Metabolic and Inflammatory Signaling. Circ Res. 2018;122:877\u2013902.","journal-title":"Circ Res"},{"key":"3171_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201102095","volume":"194","author":"T Finkel","year":"2011","unstructured":"Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011;194:7\u201315.","journal-title":"J Cell Biol"},{"key":"3171_CR38","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1089\/ars.2008.2378","volume":"11","author":"AB Fisher","year":"2009","unstructured":"Fisher AB. Redox signaling across cell membranes. Antioxid Redox Signal. 2009;11:1349\u201356.","journal-title":"Antioxid Redox Signal"},{"key":"3171_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.189.2.413","volume":"189","author":"T Miyazaki","year":"1999","unstructured":"Miyazaki T, Hirokami Y, Matsuhashi N, Takatsuka H, Naito M. Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med. 1999;189:413\u201322.","journal-title":"J Exp Med"},{"key":"3171_CR40","doi-asserted-by":"publisher","first-page":"e109123","DOI":"10.1371\/journal.pone.0109123","volume":"9","author":"T Yamazaki","year":"2014","unstructured":"Yamazaki T, Mori M, Arai S, Tateishi R, Abe M, Ban M, et al. Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans. PLoS One. 2014;9:e109123.","journal-title":"PLoS One"},{"key":"3171_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00281-018-0717-6","volume":"40","author":"S Arai","year":"2018","unstructured":"Arai S, Miyazaki T. A scavenging system against internal pathogens promoted by the circulating protein apoptosis inhibitor of macrophage (AIM). Semin Immunopathol. 2018;40:567\u201375.","journal-title":"Semin Immunopathol"},{"key":"3171_CR42","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.celrep.2013.03.006","volume":"3","author":"S Arai","year":"2013","unstructured":"Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, et al. Obesity-associated autoantibody production requires AIM to retain the immunoglobulin M immune complex on follicular dendritic cells. Cell Rep. 2013;3:1187\u201398.","journal-title":"Cell Rep"},{"key":"3171_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm.4012","volume":"22","author":"S Arai","year":"2016","unstructured":"Arai S, Kitada K, Yamazaki T, Takai R, Zhang X, Tsugawa Y, et al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med. 2016;22:183\u201393.","journal-title":"Nat Med"},{"key":"3171_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.celrep.2014.08.058","volume":"9","author":"N Maehara","year":"2014","unstructured":"Maehara N, Arai S, Mori M, Iwamura Y, Kurokawa J, Kai T, et al. Circulating AIM prevents hepatocellular carcinoma through complement activation. Cell Rep. 2014;9:61\u201374.","journal-title":"Cell Rep"},{"key":"3171_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109693","volume":"36","author":"N Maehara","year":"2021","unstructured":"Maehara N, Taniguchi K, Okuno A, Ando H, Hirota A, Li Z, et al. AIM\/CD5L attenuates DAMPs in the injured brain and thereby ameliorates ischemic stroke. Cell Rep. 2021;36:109693.","journal-title":"Cell Rep"},{"key":"3171_CR46","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcp.31097","volume":"238","author":"H Nemoto","year":"2023","unstructured":"Nemoto H, Honjo M, Arai S, Miyazaki T, Aihara M. Apoptosis inhibitor of macrophages\/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension. J Cell Physiol. 2023;238:2451\u201367.","journal-title":"J Cell Physiol"},{"key":"3171_CR47","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s42003-022-03750-w","volume":"5","author":"K Matsuura","year":"2022","unstructured":"Matsuura K, Maehara N, Hirota A, Eguchi A, Yasuda K, Taniguchi K, et al. Two independent modes of kidney stone suppression achieved by AIM\/CD5L and KIM-1. Commun Biol. 2022;5:783.","journal-title":"Commun Biol"},{"key":"3171_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103149","volume":"142","author":"K Yasuda","year":"2024","unstructured":"Yasuda K, Shimodan S, Maehara N, Hirota A, Iijima R, Nishijima A, et al. AIM\/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions. J Autoimmun. 2024;142:103149.","journal-title":"J Autoimmun"},{"key":"3171_CR49","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2010.04.013","volume":"11","author":"J Kurokawa","year":"2010","unstructured":"Kurokawa J, Arai S, Nakashima K, Nagano H, Nishijima A, Miyata K, et al. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab. 2010;11:479\u201392.","journal-title":"Cell Metab"},{"key":"3171_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06824-6","volume":"7","author":"T Tomita","year":"2017","unstructured":"Tomita T, Arai S, Kitada K, Mizuno M, Suzuki Y, Sakata F, et al. Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice. Sci Rep. 2017;7:6450.","journal-title":"Sci Rep"},{"key":"3171_CR51","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bbrc.2012.05.018","volume":"422","author":"Y Iwamura","year":"2012","unstructured":"Iwamura Y, Mori M, Nakashima K, Mikami T, Murayama K, Arai S, et al. Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes. Biochem Biophys Res Commun. 2012;422:476\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"3171_CR52","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","volume":"163","author":"C Wang","year":"2015","unstructured":"Wang C, Yosef N, Gaublomme J, Wu C, Lee Y, Clish CB, et al. CD5L\/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell. 2015;163:1413\u201327.","journal-title":"Cell"},{"key":"3171_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau1199","volume":"4","author":"E Hiramoto","year":"2018","unstructured":"Hiramoto E, Tsutsumi A, Suzuki R, Matsuoka S, Arai S, Kikkawa M, et al. The IgM pentamer is an asymmetric pentagon with an open groove that binds the AIM protein. Sci Adv. 2018;4:eaau1199.","journal-title":"Sci Adv"},{"key":"3171_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53615-5","volume":"15","author":"Q Chen","year":"2024","unstructured":"Chen Q, Ishii K, Mori H, Nishijima A, Arai S, Miyazaki T, et al. Cryo-EM reveals structural basis for human AIM\/CD5L recognition of polymeric immunoglobulin M. Nat Commun. 2024;15:9387.","journal-title":"Nat Commun"},{"key":"3171_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s43856-025-00735-8","volume":"5","author":"K Yasuda","year":"2025","unstructured":"Yasuda K, Nishijima A, Inoue T, Takagi T, Tanabe K, Minakuchi J, et al. Release of apoptosis inhibitor of macrophage (AIM) from pentameric IgM in serum predicts prognosis after hemodialysis initiation. Commun Med. 2025;5:15.","journal-title":"Commun Med"},{"key":"3171_CR56","doi-asserted-by":"publisher","first-page":"e0260449","DOI":"10.1371\/journal.pone.0260449","volume":"16","author":"CT Wang","year":"2021","unstructured":"Wang CT, Tezuka T, Takeda N, Araki K, Arai S, Miyazaki T. High salt exacerbates acute kidney injury by disturbing the activation of CD5L\/apoptosis inhibitor of macrophage (AIM) protein. PLoS One. 2021;16:e0260449.","journal-title":"PLoS One"},{"key":"3171_CR57","doi-asserted-by":"publisher","first-page":"e0249838","DOI":"10.1371\/journal.pone.0249838","volume":"16","author":"JY Lee","year":"2021","unstructured":"Lee JY, Arumugarajah S, Lian D, Maehara N, Haig AR, Suri RS, et al. Recombinant apoptosis inhibitor of macrophage protein reduces delayed graft function in a murine model of kidney transplantation. PLoS One. 2021;16:e0249838.","journal-title":"PLoS One"},{"key":"3171_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/srep35251","volume":"6","author":"R Sugisawa","year":"2016","unstructured":"Sugisawa R, Hiramoto E, Matsuoka S, Iwai S, Takai R, Yamazaki T, et al. Impact of feline AIM on the susceptibility of cats to renal disease. Sci Rep. 2016;6:35251.","journal-title":"Sci Rep"},{"key":"3171_CR59","doi-asserted-by":"publisher","first-page":"141.","DOI":"10.3390\/biom9040141","volume":"9","author":"E Mart\u00ednez-Klimova","year":"2019","unstructured":"Mart\u00ednez-Klimova E, Aparicio-Trejo OE, Tapia E, Pedraza-Chaverri J. Unilateral Ureteral obstruction as a model to investigate fibrosis-attenuating treatments. Biomolecules. 2019;9:141.","journal-title":"Biomolecules"},{"key":"3171_CR60","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.cmet.2022.09.026","volume":"34","author":"H Li","year":"2022","unstructured":"Li H, Dixon EE, Wu H, Humphreys BD. Comprehensive single-cell transcriptional profiling defines shared and unique epithelial injury responses during kidney fibrosis. Cell Metab. 2022;34:1977\u201398.e9.","journal-title":"Cell Metab"},{"key":"3171_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mrgentox.2007.04.006","volume":"631","author":"I Hayashi","year":"2007","unstructured":"Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res. 2007;631:55\u201361.","journal-title":"Mutat Res"},{"key":"3171_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","volume":"16","author":"K Taguchi","year":"2011","unstructured":"Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1\u2013Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011;16:123\u201340.","journal-title":"Genes Cells"},{"key":"3171_CR63","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1089\/ars.2010.3221","volume":"13","author":"JD Hayes","year":"2010","unstructured":"Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal. 2010;13:1713\u201348.","journal-title":"Antioxid Redox Signal"},{"key":"3171_CR64","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1128\/MCB.01704-07","volume":"28","author":"T Yamamoto","year":"2008","unstructured":"Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, et al. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol. 2008;28:2758\u201370.","journal-title":"Mol Cell Biol"},{"key":"3171_CR65","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1194\/jlr.M700464-JLR200","volume":"49","author":"RS Faustino","year":"2008","unstructured":"Faustino RS, Cheung P, Richard MN, Dibrov E, Kneesch AL, Deniset JF, et al. Ceramide regulation of nuclear protein import. J Lipid Res. 2008;49:654\u201362.","journal-title":"J Lipid Res"},{"key":"3171_CR66","doi-asserted-by":"publisher","first-page":"E5549","DOI":"10.1073\/pnas.1705134114","volume":"114","author":"MV Airola","year":"2017","unstructured":"Airola MV, Shanbhogue P, Shamseddine AA, Guja KE, Senkal CE, Maini R, et al. Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation. Proc Natl Acad Sci USA. 2017;114:E5549\u201358.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3171_CR67","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan Y, Zhang D, Zhou P, Li B, Huang SY. HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy. Nucleic Acids Res. 2017;45:W365\u201373.","journal-title":"Nucleic Acids Res"},{"key":"3171_CR68","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/prot.25234","volume":"85","author":"Y Yan","year":"2017","unstructured":"Yan Y, Wen Z, Wang X, Huang SY. Addressing recent docking challenges: A hybrid strategy to integrate template-based and free protein-protein docking. Proteins. 2017;85:497\u2013512.","journal-title":"Proteins"},{"key":"3171_CR69","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.3390\/ijms14047716","volume":"14","author":"R Mart\u00ednez-Beamonte","year":"2013","unstructured":"Mart\u00ednez-Beamonte R, Lou-Bonafonte JM, Mart\u00ednez-Gracia MV, Osada J. Sphingomyelin in high-density lipoproteins: structural role and biological function. Int J Mol Sci. 2013;14:7716\u201341.","journal-title":"Int J Mol Sci"},{"key":"3171_CR70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.kint.2024.01.041","volume":"106","author":"EO Asowata","year":"2024","unstructured":"Asowata EO, Romoli S, Sargeant R, Tan JY, Hoffmann S, Huang MM, et al. Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function. Kidney Int. 2024;106:85\u201397.","journal-title":"Kidney Int"},{"key":"3171_CR71","doi-asserted-by":"publisher","first-page":"e97037","DOI":"10.1371\/journal.pone.0097037","volume":"9","author":"T Kai","year":"2014","unstructured":"Kai T, Yamazaki T, Arai S, Miyazaki T. Stabilization and augmentation of circulating AIM in mice by synthesized IgM-Fc. PLoS One. 2014;9:e97037.","journal-title":"PLoS One"},{"key":"3171_CR72","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1194\/jlr.M700227-JLR200","volume":"48","author":"K Rutkute","year":"2007","unstructured":"Rutkute K, Asmis RH, Nikolova-Karakashian MN. Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation. J Lipid Res. 2007;48:2443\u201352.","journal-title":"J Lipid Res"},{"key":"3171_CR73","doi-asserted-by":"publisher","first-page":"C538","DOI":"10.1152\/ajpcell.00144.2023","volume":"325","author":"X Wang","year":"2023","unstructured":"Wang X, Song M, Li X, Su C, Yang Y, Wang K, et al. CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease. Am J Physiol Cell Physiol. 2023;325:C538\u201349.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3171_CR74","doi-asserted-by":"publisher","first-page":"190.","DOI":"10.3390\/biomedicines12010190","volume":"12","author":"MF Lopes-Virella","year":"2024","unstructured":"Lopes-Virella MF, Hammad SM, Baker NL, Klein RL, Hunt KJ. Circulating Lipoprotein Sphingolipids in chronic kidney disease with and without diabetes. Biomedicines. 2024;12:190.","journal-title":"Biomedicines"},{"key":"3171_CR75","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1161\/hh2301.100350","volume":"89","author":"T Levade","year":"2001","unstructured":"Levade T, Aug\u00e9 N, Veldman RJ, Cuvillier O, N\u00e8gre-Salvayre A, Salvayre R. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ Res. 2001;89:957\u201368.","journal-title":"Circ Res"},{"key":"3171_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1139\/o03-091","volume":"82","author":"N Marchesini","year":"2004","unstructured":"Marchesini N, Hannun YA. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol. 2004;82:27\u201344.","journal-title":"Biochem Cell Biol"},{"key":"3171_CR77","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1210\/er.2007-0025","volume":"29","author":"WL Holland","year":"2008","unstructured":"Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev. 2008;29:381\u2013402.","journal-title":"Endocr Rev"},{"key":"3171_CR78","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1096\/fj.08-108043","volume":"22","author":"EL Smith","year":"2008","unstructured":"Smith EL, Schuchman EH. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 2008;22:3419\u201331.","journal-title":"FASEB J"},{"key":"3171_CR79","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/cvr\/cvp030","volume":"82","author":"C Pavoine","year":"2009","unstructured":"Pavoine C, Pecker F. Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology. Cardiovasc Res. 2009;82:175\u201383.","journal-title":"Cardiovasc Res"},{"key":"3171_CR80","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cmet.2022.05.010","volume":"34","author":"H Wu","year":"2022","unstructured":"Wu H, Gonzalez Villalobos R, Yao X, Reilly D, Chen T, Rankin M, et al. Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies. Cell Metab. 2022;34:1064\u201378.e6.","journal-title":"Cell Metab"},{"key":"3171_CR81","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41587-020-0531-2","volume":"38","author":"H Tsugawa","year":"2020","unstructured":"Tsugawa H, Ikeda K, Takahashi M, Satoh A, Mori Y, Uchino H, et al. A lipidome atlas in MS-DIAL 4. Nat Biotechnol. 2020;38:1159\u201363.","journal-title":"Nat Biotechnol"},{"key":"3171_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add4346","volume":"8","author":"Y Endo","year":"2023","unstructured":"Endo Y, Kanno T, Nakajima T, Ikeda K, Taketomi Y, Yokoyama S, et al. 1-Oleoyl-lysophosphatidylethanolamine stimulates ROR\u03b3t activity in T(H)17 cells. Sci Immunol. 2023;8:eadd4346.","journal-title":"Sci Immunol"},{"key":"3171_CR83","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jchromb.2015.05.015","volume":"995-996","author":"M Yamada","year":"2015","unstructured":"Yamada M, Kita Y, Kohira T, Yoshida K, Hamano F, Tokuoka SM, et al. A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography\/mass spectrometry with high speed continuous ionization polarity switching. J Chromatogr B Anal Technol Biomed Life Sci. 2015;995-996:74\u201384.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"3171_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/737591","volume":"2013","author":"D T\u00fcrei","year":"2013","unstructured":"T\u00fcrei D, Papp D, Fazekas D, F\u00f6ldv\u00e1ri-Nagy L, M\u00f3dos D, Lenti K, et al. NRF2-ome: an integrated web resource to discover protein interaction and regulatory networks of NRF2. Oxid Med Cell Longev. 2013;2013:737591.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03171-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:02:39Z","timestamp":1784192559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03171-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03171-2","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Animal experiments\n                      : The study protocol was approved by the Animal Welfare Committee of Tokyo Women\u2019s Medical University (approval numbers: AE24-106-B and GE24-099-B).\n                      Human participants\n                      : This study analyzed serum samples and clinical data from patients with CKD, including stage G1 and stage G5 cases, obtained from Kawashima Hospital in Tokushima, Japan. Serum samples were also collected from healthy individuals undergoing annual health checkups at Inoue Hospital in Nagasaki, Japan. Written informed consent was obtained from all serum donors. The study adhered to the ethical guidelines outlined in the 1975 Declaration of Helsinki and received approval from the Ethics Committees of the University of Tokyo for Medical Experiments (Approval nos. 2019338NI and 2019278NI) and Kawashima Hospital (Approval no. 0744\u20130750).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"311"}}